The FDA has approved a new drug for patients with ALK-positive lung cancer. The drug is called brigatinib (brand name: Alunbrig) and is approved for treatment of patients whose tumor has the ALK mutation. Brigatinib is to be used after another drug targeting ALK stops working. The FDA press release is here: fda.gov/Drugs/InformationOn.... This is great news as it gives patients with the ALK mutation another treatment option.
A new drug for ALK-positive lung cance... - Lung Cancer Support
A new drug for ALK-positive lung cancer approved today
Written by
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
DenzieModeratorVolunteer
This is the 8th new treatment approved in the last 2 years. It's an exciting time to be an advocate.
This is terrific news!!! Thanks for sharing!
Keep the good news coming, Mary!
I live in Colorado. What about medical marijuana. I have stage4 lung cancer and am seeing my dr today
Not what you're looking for?
You may also like...
First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)
On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...
Opdivo and Yervoy combination approved for Non-small cell lung cancer
More exciting approval announcements for this week.
On May 15th, 2020, the Food and Drug...
FDA approves another blood test for a mutation (T790M) in lung cancer
Some of you may have heard about new blood tests to check for lung cancer mutations. And you may...
FDA approval for Investigational drug Small Cell Lung Cancer
Hello all,
FDA approved APG-1252 as a investigational drug for treatment for small cell on or about...
FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression
On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the...
Related Posts
FDA Approves Keytruda Combo for Lung Cancer- Study presented at the European Society for Medical Oncology (ESMO) Congress may mean a new way to treat patients with stage 3 lung cancer
- New drug approved for patients with MET mutation.
- An immunotherapy now approved for first-line treatment
A Lung Cancer Blogger's Story
